| Title |
Safety concerns and hidden agenda behind HPV vaccines: another generation of drug‐dependent society?
|
|---|---|
| Published in |
Clinical and Translational Medicine, December 2016
|
| DOI | 10.1186/s40169-016-0126-1 |
| Pubmed ID | |
| Authors |
Mahin Khatami |
| Abstract |
Analyses of data and hidden agenda behind repeated failed outcomes of cancer research and therapy, status of American health, safety concerns for HPV vaccines and future research considerations are summarized in this commentary. A closer look at cancer science reveals that highly power structure (system) in medical establishment vs. anti-system and chaos in cancer research ('medical/scientific ponzi schemes') is potent recipe for failed therapeutics that kills patients but generates huge corporate profit. American health status ranks last among other developed nations despite the highest amount that USA invests in healthcare. This is a wake-up call to make sure that the evil part of human being does not prevent the health services that the public deserves. Otherwise, 'it does not matter how many resources you have, if you don't know, or don't want to know, how to use them, they will never be enough'. Answer to cancer and improved public health is possible only by switching the current corruptive and abusive culture of 'who you know' to a culture of 'what you know'. Policy makers and professionals in decision making roles are urged to return to common sense and logics that our Forefathers used to serve the public. |
X Demographics
The data shown below were collected from the profiles of 235 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 43 | 18% |
| Japan | 10 | 4% |
| United Kingdom | 7 | 3% |
| Ireland | 4 | 2% |
| Canada | 3 | 1% |
| Croatia | 2 | <1% |
| South Africa | 2 | <1% |
| Côte d'Ivoire | 1 | <1% |
| Netherlands | 1 | <1% |
| Other | 14 | 6% |
| Unknown | 148 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 207 | 88% |
| Practitioners (doctors, other healthcare professionals) | 12 | 5% |
| Scientists | 10 | 4% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 41 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 27% |
| Student > Ph. D. Student | 7 | 17% |
| Researcher | 6 | 15% |
| Student > Postgraduate | 3 | 7% |
| Other | 3 | 7% |
| Other | 5 | 12% |
| Unknown | 6 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 29% |
| Psychology | 3 | 7% |
| Economics, Econometrics and Finance | 3 | 7% |
| Agricultural and Biological Sciences | 3 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Other | 8 | 20% |
| Unknown | 10 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 181. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#226,280
of 25,753,031 outputs
Outputs from Clinical and Translational Medicine
#10
of 1,080 outputs
Outputs of similar age
#4,546
of 418,773 outputs
Outputs of similar age from Clinical and Translational Medicine
#1
of 8 outputs
Altmetric has tracked 25,753,031 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,080 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 418,773 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them